To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene CD82TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
382 supporting clones for gene CD82 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
BP273292   .a 1 to 559 4 to 562       562/562
(100 %)
1 diff
(99.9 %id)
DA850535 placenta .a 1 to 541 2 to 542   tiling clone, capped   541/541
(100 %)
0 diff
(100 %id)
DB273305 uterus .a 1 to 546 2 to 547   capped   546/546
(100 %)
2 diff
(99.7 %id)
CR609000 Placenta Cot 25-normalized .a 15 to 1670 1 to 1656 exact     1656/1656
(100 %)
0 diff
(100 %id)
AL543159 placenta, Placenta Cot 25-normalized .a 15 to 933 1 to 916   fully sequenced,   916/916
(100 %)
8 diff
(99.2 %id)
NM_002231.3   .a 15 to 1703 1 to 1689 exact RefSeq, AAA Possibly primed on the genome, locally A rich (26/26 A in genome downstream of last aligned base) 1689/1689
(100 %)
0 diff
(100 %id)
BP381853 adipose tissue .a 23 to 638 1 to 616       616/616
(100 %)
1 diff
(99.9 %id)
BP305865   .a 23 to 600 1 to 577       577/577
(100 %)
1 diff
(99.9 %id)
DA201793 brain .a 24 to 576 2 to 554   capped   553/553
(100 %)
0 diff
(100 %id)
DA836817 placenta .a 24 to 580 2 to 559   capped   558/558
(100 %)
2 diff
(99.7 %id)
DB194360 trachea .a 24 to 714 2 to 694   capped   693/816
(84 %)
7 diff
(99.2 %id)
BP300988   .a 25 to 606 1 to 582       582/582
(100 %)
0 diff
(100 %id)
CV570329 cornea, eye .a 34 to 657 1 to 624       624/624
(100 %)
0 diff
(100 %id)
BF664387 B-cells, primary B-cells from tonsils (cell line) .a 37 to 882 1 to 839       839/1054
(79 %)
22 diff
(98.0 %id)
DA586410 lung .a 42 to 631 2 to 591   capped   590/590
(100 %)
0 diff
(100 %id)
BP254925 Kidney .a 42 to 623 1 to 582       582/582
(100 %)
1 diff
(99.9 %id)
DB129092 thymus .a 42 to 596 2 to 556   capped   555/555
(100 %)
0 diff
(100 %id)
BP294719   .a 47 to 628 1 to 582       582/582
(100 %)
1 diff
(99.9 %id)
BI113781 muscle, rhabdomyosarcoma .a 49 to 704 1 to 656       656/657
(99 %)
3 diff
(99.6 %id)
TI_57219227   .a 55 to 741 57 to 743       683/745
(91 %)
7 diff
(99.1 %id)
BX340291 Placenta Cot 25-normalized .a 59 to 670 1 to 611       611/611
(100 %)
3 diff
(99.6 %id)
BI753805 brain .a 59 to 741 1 to 683       683/685
(99 %)
1 diff
(99.9 %id)
AK225708 thymus .a 61 to 1703 1 to 1643 I241V AAA Possibly primed on the genome, locally A rich (26/26 A in genome downstream of last aligned base) 1643/1643
(100 %)
4 diff
(99.8 %id)
BG545481 lung .a 61 to 714 1 to 660       660/1108
(59 %)
25 diff
(97.8 %id)
BP324131 Pancreas .a 61 to 641 1 to 581       581/581
(100 %)
1 diff
(99.9 %id)
BP366951 thymus .a 61 to 642 1 to 582       582/582
(100 %)
0 diff
(100 %id)
BP254693 Kidney .a 62 to 638 1 to 578       578/582
(99 %)
3 diff
(99.5 %id)
BP297319   .a 62 to 644 1 to 582       582/582
(100 %)
2 diff
(99.7 %id)
BP297639   .a 62 to 639 1 to 580       578/580
(99 %)
3 diff
(99.5 %id)
BP299515   .a 62 to 644 1 to 582       582/582
(100 %)
1 diff
(99.9 %id)
BP300376   .a 62 to 641 1 to 580       580/580
(100 %)
0 diff
(100 %id)
DA704683   .a 62 to 556 2 to 496   capped   495/496
(99 %)
1 diff
(99.8 %id)
DA355748 subthalamic nucleus .a 63 to 621 2 to 560   capped   559/559
(100 %)
1 diff
(99.9 %id)
DB109978 thymus .a 63 to 633 2 to 572   capped   571/571
(100 %)
0 diff
(100 %id)
DB119481 thymus .a 63 to 598 2 to 537   capped   536/537
(99 %)
1 diff
(99.9 %id)
AU138278 placenta .a 64 to 715 2 to 655   capped   654/775
(84 %)
13 diff
(98.4 %id)
DA078116 cerebellum .a 66 to 642 2 to 578   capped   577/577
(100 %)
0 diff
(100 %id)
DA139740 alzheimer cortex .a 66 to 642 2 to 578   capped   577/577
(100 %)
2 diff
(99.7 %id)
DA139809 alzheimer cortex .a 66 to 642 2 to 578   capped   577/577
(100 %)
2 diff
(99.7 %id)
DA441754 tongue, tumor tissue .a 66 to 618 2 to 554   capped   553/553
(100 %)
1 diff
(99.9 %id)
DA584064 lung .a 66 to 670 2 to 606   capped   605/605
(100 %)
0 diff
(100 %id)
DA694660   .a 66 to 623 2 to 559   capped   558/558
(100 %)
1 diff
(99.9 %id)
DA716534   .a 66 to 585 2 to 521   capped   520/520
(100 %)
0 diff
(100 %id)
DB126169 thymus .a 66 to 606 2 to 542   capped   541/541
(100 %)
0 diff
(100 %id)
DA156088 amygdala .a 67 to 628 2 to 563   capped   562/562
(100 %)
0 diff
(100 %id)
AL709099 human skeletal muscle .a 70 to 800 1 to 736       736/760
(96 %)
5 diff
(99.4 %id)
BG327471 Kidney, renal cell adenocarcinoma .a 70 to 870 1 to 793       793/852
(93 %)
16 diff
(98.2 %id)
BP295410   .a 70 to 649 1 to 580       580/580
(100 %)
1 diff
(99.9 %id)
CR593263 fetal liver .a 71 to 1645 1 to 1575 exact     1575/1575
(100 %)
0 diff
(100 %id)
BX416926 placenta .a 71 to 1037 1 to 964       964/964
(100 %)
8 diff
(99.2 %id)
BX405862 fetal liver, Liver .a 71 to 961 1 to 891   fully sequenced,   891/891
(100 %)
4 diff
(99.6 %id)
BG762132 melanotic melanoma, high MDR (cell line), skin .a 72 to 910 1 to 839       839/977
(85 %)
15 diff
(98.5 %id)
BG763336 melanotic melanoma, high MDR (cell line), skin .a 72 to 901 1 to 835       835/835
(100 %)
16 diff
(98.1 %id)
BM008997 adenocarcinoma, Pancreas .a 72 to 941 1 to 866       866/867
(99 %)
19 diff
(97.9 %id)
TI_59386721   .a 73 to 941 123 to 987       865/866
(99 %)
18 diff
(98.0 %id)
AL710883 human skeletal muscle .a 74 to 915 1 to 853       853/860
(99 %)
22 diff
(97.5 %id)
BF205723 muscle, rhabdomyosarcoma .a 75 to 855 1 to 780       780/880
(88 %)
25 diff
(97.2 %id)
BF305205 muscle, rhabdomyosarcoma .a 75 to 807 1 to 730       730/845
(86 %)
10 diff
(98.9 %id)
BF307381 muscle, rhabdomyosarcoma .a 76 to 848 1 to 769       767/918
(83 %)
23 diff
(97.5 %id)
BE019101 muscle, rhabdomyosarcoma .a 77 to 697 1 to 621       621/621
(100 %)
7 diff
(98.9 %id)
BG824478 adenocarcinoma cell line, colon .a 77 to 905 1 to 827       827/1056
(78 %)
22 diff
(98.0 %id)
BQ688811 ductal carcinoma, cell line, Pancreas .a 81 to 914 1 to 839       839/938
(89 %)
14 diff
(98.6 %id)
BP300125   .a 82 to 663 1 to 582       582/582
(100 %)
1 diff
(99.9 %id)
DB106208 thymus .a 82 to 632 2 to 552   capped   551/551
(100 %)
0 diff
(100 %id)
DA199539 brain .a 86 to 672 2 to 588   capped   587/587
(100 %)
0 diff
(100 %id)
BX487126   .a 86 to 767 1 to 682       682/682
(100 %)
4 diff
(99.5 %id)
DA587426 lung .a 86 to 682 2 to 598   capped   597/597
(100 %)
2 diff
(99.7 %id)
BM914425 Spleen .a 86 to 913 1 to 828       828/973
(85 %)
23 diff
(97.7 %id)
DB008456 cervix, tumor tissue .a 86 to 534 2 to 451   capped   450/450
(100 %)
3 diff
(99.4 %id)
BG420128 Kidney, renal cell adenocarcinoma .a 87 to 833 1 to 745       745/1006
(74 %)
11 diff
(99.0 %id)
BP295578   .a 87 to 665 1 to 581       581/581
(100 %)
2 diff
(99.7 %id)
BP301271   .a 87 to 669 1 to 583       583/583
(100 %)
1 diff
(99.9 %id)
BP303227   .a 87 to 667 1 to 581       581/581
(100 %)
1 diff
(99.9 %id)
BP306175   .a 87 to 665 1 to 579       579/579
(100 %)
1 diff
(99.9 %id)
DA590114 lung .a 88 to 648 2 to 562   capped   561/561
(100 %)
0 diff
(100 %id)
BE870989 adenocarcinoma, colon .a 88 to 796 1 to 722       722/1065
(67 %)
27 diff
(97.5 %id)
DA668272 esophagus .a 88 to 576 2 to 498   capped   495/501
(98 %)
11 diff
(97.9 %id)
DA688160   .a 88 to 628 2 to 542   capped   541/541
(100 %)
1 diff
(99.9 %id)
DA707757   .a 88 to 667 2 to 581   capped   580/580
(100 %)
0 diff
(100 %id)
DA834858 placenta .a 88 to 808 2 to 725   capped   724/726
(99 %)
12 diff
(98.4 %id)
DA927029 small intestine .a 88 to 669 2 to 583   capped   582/582
(100 %)
0 diff
(100 %id)
DA953039 Spleen .a 88 to 662 2 to 578   capped   577/577
(100 %)
2 diff
(99.7 %id)
DB138384 thymus .a 88 to 614 2 to 528   capped   527/527
(100 %)
0 diff
(100 %id)
BP380759   .a 88 to 690 1 to 602       602/602
(100 %)
15 diff
(97.6 %id)
AK225410 Kidney .a 89 to 1703 1 to 1615 I241V AAA Possibly primed on the genome, locally A rich (26/26 A in genome downstream of last aligned base) 1615/1615
(100 %)
4 diff
(99.8 %id)
AK312677   .a 89 to 1066 1 to 978 I241V     978/978
(100 %)
1 diff
(99.9 %id)
DA521472 brain .a 89 to 639 2 to 552   capped   551/551
(100 %)
0 diff
(100 %id)
BP255183 Kidney .a 89 to 692 1 to 604       604/604
(100 %)
1 diff
(99.9 %id)
TI_44000933   .a 89 to 677 92 to 680       585/680
(86 %)
7 diff
(99.0 %id)
BP278789   .a 89 to 598 1 to 510       510/520
(98 %)
2 diff
(99.7 %id)
BP278962   .a 89 to 680 1 to 592       592/592
(100 %)
1 diff
(99.9 %id)
BP290001 lung .a 89 to 672 1 to 584       584/584
(100 %)
0 diff
(100 %id)
BP295597   .a 89 to 670 1 to 582       582/582
(100 %)
1 diff
(99.9 %id)
BP351837   .a 89 to 669 1 to 581       581/581
(100 %)
4 diff
(99.4 %id)
DN996093 breast cancer, Mammary gland (cancer tissue) .a 89 to 558 6 to 475       470/475
(98 %)
8 diff
(98.4 %id)
DA084370 cerebellum .a 90 to 560 2 to 473   capped   472/472
(100 %)
1 diff
(99.8 %id)
CN265479 embryonic stem cells, cell lines H1, H7, andH9 .a 90 to 742 8 to 661       650/661
(98 %)
9 diff
(98.7 %id)
CA394402 eye, RPE/choroid .a 90 to 659 1 to 570       570/570
(100 %)
1 diff
(99.9 %id)
DA470169   .a 90 to 653 2 to 565   capped   564/564
(100 %)
2 diff
(99.7 %id)
DA495489 brain .a 90 to 654 2 to 566   capped   565/565
(100 %)
1 diff
(99.9 %id)
DA504468 brain .a 90 to 558 2 to 471   capped   470/470
(100 %)
1 diff
(99.8 %id)
DA541034 lung .a 90 to 673 2 to 585   capped   584/584
(100 %)
2 diff
(99.7 %id)
DA582894 lung .a 90 to 689 2 to 602   capped   601/601
(100 %)
3 diff
(99.6 %id)
DA587678 lung .a 90 to 637 2 to 549   capped   548/548
(100 %)
0 diff
(100 %id)
DA588484 lung .a 90 to 640 2 to 552   capped   551/551
(100 %)
0 diff
(100 %id)
BP303562   .a 90 to 680 1 to 591       591/591
(100 %)
1 diff
(99.9 %id)
DA689286   .a 90 to 633 2 to 545   capped   544/544
(100 %)
0 diff
(100 %id)
DA706490   .a 90 to 657 2 to 569   capped   568/568
(100 %)
0 diff
(100 %id)
DA748642   .a 90 to 654 2 to 566   capped   565/565
(100 %)
0 diff
(100 %id)
DA849415 placenta .a 90 to 626 2 to 538   capped   537/537
(100 %)
1 diff
(99.9 %id)
DA974788 synovial membrane tissue from rheumatioidarthritis .a 90 to 585 2 to 498   capped   497/497
(100 %)
1 diff
(99.8 %id)
DB127539 thymus .a 90 to 627 2 to 539   capped   538/538
(100 %)
0 diff
(100 %id)
DB234809 trachea .a 90 to 649 2 to 561   capped   560/560
(100 %)
0 diff
(100 %id)
BG386211 adenocarcinoma cell line, colon .a 91 to 869 1 to 784       784/821
(95 %)
19 diff
(97.7 %id)
BG746427 adenocarcinoma cell line, colon .a 91 to 914 1 to 826       826/829
(99 %)
19 diff
(97.8 %id)
BP320650 placenta .a 92 to 675 1 to 584       584/584
(100 %)
1 diff
(99.9 %id)
TI_154187847   .a 92 to 834 121 to 861       741/948
(78 %)
25 diff
(97.4 %id)
BP219441 caudate nucleus .a 93 to 675 1 to 583       583/583
(100 %)
1 diff
(99.9 %id)
BP301295   .a 93 to 672 1 to 580       580/580
(100 %)
1 diff
(99.9 %id)
CR606617 Placenta Cot 25-normalized .a 94 to 1675 1 to 1582 exact tiling clone,   1582/1582
(100 %)
0 diff
(100 %id)
AL554019 placenta, Placenta Cot 25-normalized .a 94 to 935 1 to 839   fully sequenced,   839/839
(100 %)
6 diff
(99.3 %id)
AU119989 whole embryo, mainly head .a 94 to 903 2 to 814   capped   811/838
(96 %)
10 diff
(98.9 %id)
BG163723 hypernephroma, cell line, Kidney .a 94 to 714 1 to 628       628/1070
(58 %)
19 diff
(98.3 %id)
CN265482 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 95 to 803 1 to 709       709/709
(100 %)
3 diff
(99.6 %id)
BE296864 muscle, rhabdomyosarcoma .a 95 to 566 1 to 473       473/474
(99 %)
2 diff
(99.6 %id)
BM051209 eye, normal pigmented retinal epithelium .a 95 to 942 1 to 854       854/859
(99 %)
21 diff
(97.6 %id)
BF976707 B-cells, primary B-cells from tonsils (cell line) .a 96 to 855 1 to 763       763/1061
(71 %)
25 diff
(97.7 %id)
BG328337 adenocarcinoma cell line, colon .a 96 to 854 1 to 756       756/1082
(69 %)
18 diff
(98.4 %id)
BG468969 adenocarcinoma cell line, colon .a 96 to 965 1 to 868       868/871
(99 %)
27 diff
(97.0 %id)
BG822746 adenocarcinoma cell line, colon .a 96 to 866 1 to 772       772/772
(100 %)
5 diff
(99.4 %id)
BI837516 pooled pancreas and spleen .a 96 to 896 1 to 802       802/804
(99 %)
20 diff
(97.6 %id)
BM473622 melanotic melanoma, skin .a 96 to 1135 1 to 1043 E181X E182R D183G N184Q S185Q ...     1043/1078
(96 %)
25 diff
(97.7 %id)
TI_57165728   .a 96 to 896 36 to 837       798/839
(95 %)
25 diff
(97.1 %id)
BG759651 B-cells, primary B-cells from tonsils (cell line) .a 97 to 943 1 to 846       846/846
(100 %)
12 diff
(98.6 %id)
BM808901 brain, hippocampus .a 97 to 903 9 to 816   AAA   804/1005
(80 %)
9 diff
(99.2 %id)
S48196   .a 97 to 1703 1 to 1607 I240M I241V AAA Possibly primed on the genome, locally A rich (26/26 A in genome downstream of last aligned base) 1607/1607
(100 %)
5 diff
(99.7 %id)
TI_154187809   .a 97 to 907 123 to 925       803/932
(86 %)
14 diff
(98.5 %id)
BG324120 Kidney, renal cell adenocarcinoma .a 98 to 919 1 to 808       808/831
(97 %)
34 diff
(96.0 %id)
U20770   .a 98 to 1705 1 to 1607 exact     1607/1607
(100 %)
3 diff
(99.9 %id)
BG821100 adenocarcinoma cell line, colon .a 99 to 814 1 to 723       719/726
(99 %)
12 diff
(98.4 %id)
CV574450 cornea, eye .a 99 to 727 1 to 629       629/629
(100 %)
0 diff
(100 %id)
CR615871 Placenta Cot 25-normalized .a 100 to 1670 1 to 1571 exact     1571/1571
(100 %)
0 diff
(100 %id)
AL546425 placenta, Placenta Cot 25-normalized .a 100 to 935 1 to 834   fully sequenced,   834/834
(100 %)
2 diff
(99.8 %id)
BP303625   .a 100 to 681 1 to 582       582/582
(100 %)
0 diff
(100 %id)
BG386747 adenocarcinoma cell line, colon .a 101 to 913 1 to 810       810/1023
(79 %)
19 diff
(98.2 %id)
BG468458 adenocarcinoma cell line, colon .a 101 to 912 1 to 813       813/868
(93 %)
13 diff
(98.6 %id)
BQ641899 eye, normal pigmented retinal epithelium .a 101 to 991 1 to 893       893/919
(97 %)
20 diff
(97.9 %id)
CV574120 cornea, eye .a 102 to 728 1 to 627       627/627
(100 %)
0 diff
(100 %id)
BG328605 adenocarcinoma cell line, colon .a 105 to 870 1 to 763       763/764
(99 %)
7 diff
(99.1 %id)
CN265481 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 106 to 821 1 to 717       717/717
(100 %)
1 diff
(99.9 %id)
BF530617 anaplastic oligodendroglioma with 1p/19qloss, brain .a 106 to 915 1 to 812       812/871
(93 %)
16 diff
(98.2 %id)
BG741307 skin .a 106 to 910 1 to 812       812/849
(95 %)
12 diff
(98.6 %id)
BG740864 skin .a 107 to 957 1 to 847       847/847
(100 %)
19 diff
(97.8 %id)
X53795 PBL .a 107 to 1714 1 to 1608 exact     1608/2049
(78 %)
6 diff
(99.8 %id)
BX382474 Placenta Cot 25-normalized .a 108 to 1209 1 to 1085 Y88F R132C D134V D160B Y212F ...     1085/1085
(100 %)
34 diff
(96.9 %id)
BU181444 epithelioid carcinoma, Pancreas .a 108 to 909 1 to 809       809/878
(92 %)
12 diff
(98.7 %id)
CX751869 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .a 109 to 872 1 to 750       750/891
(84 %)
17 diff
(98.1 %id)
BM846925 myeloma .a 109 to 636 1 to 528       528/528
(100 %)
2 diff
(99.7 %id)
AA922309 adenocarcinoma, colon .a 110 to 538 430 to 3       428/439
(97 %)
21 diff
(95.3 %id)
BG104593 adrenal cortex carcinoma, cell line, adrenal gland .a 113 to 882 1 to 762       762/790
(96 %)
21 diff
(97.4 %id)
TI_154185898   .a 113 to 905 119 to 906       788/968
(81 %)
25 diff
(97.5 %id)
AA401055 ovarian tumor, ovary .a 115 to 602 1 to 488       488/519
(94 %)
16 diff
(97.0 %id)
BC000726 Colon, adenocarcinoma .a 117 to 1703 1 to 1587 I241V available from MGC, AAA Possibly primed on the genome, locally A rich (26/26 A in genome downstream of last aligned base) 1587/1587
(100 %)
2 diff
(99.9 %id)
BC001821 Colon, adenocarcinoma .a 117 to 1703 1 to 1587   available from MGC, AAA Possibly primed on the genome, locally A rich (26/26 A in genome downstream of last aligned base) 1587/1587
(100 %)
2 diff
(99.9 %id)
TI_154188445   .a 119 to 993 120 to 990       871/928
(93 %)
32 diff
(96.6 %id)
BG821991 adenocarcinoma cell line, colon .a 121 to 947 1 to 836       836/836
(100 %)
20 diff
(97.7 %id)
BE871165 adenocarcinoma, colon .a 123 to 919 1 to 793       793/1093
(72 %)
25 diff
(97.8 %id)
BE872332 adenocarcinoma, colon .a 126 to 833 1 to 704       704/850
(82 %)
12 diff
(98.6 %id)
TI_652739961   .a 129 to 593 480 to 14     Submitted on the opposite strand 467/484
(96 %)
1 diff
(99.8 %id)
BG821089 adenocarcinoma cell line, colon .a 130 to 900 1 to 770       770/770
(100 %)
10 diff
(98.8 %id)
BE250019 adenocarcinoma cell line, colon .a 136 to 910 1 to 777       777/1085
(71 %)
19 diff
(98.3 %id)
BE305076 adenocarcinoma cell line, colon .a 136 to 750 1 to 616       616/616
(100 %)
3 diff
(99.6 %id)
BE249958 adenocarcinoma cell line, colon .a 136 to 982 1 to 850       850/972
(87 %)
27 diff
(97.3 %id)
BE293674 adenocarcinoma cell line, colon .a 136 to 652 1 to 517       517/517
(100 %)
0 diff
(100 %id)
BM837794 Ascites, stomach .a 141 to 766 1 to 626       626/626
(100 %)
1 diff
(99.9 %id)
BF130697 hypernephroma, Kidney .a 145 to 695 1 to 559       557/834
(66 %)
14 diff
(98.4 %id)
BX405141 T cells (Jurkat cell line) .a 146 to 978 49 to 880       832/993
(83 %)
22 diff
(97.8 %id)
AU119042 whole embryo, mainly head .a 146 to 606 2 to 462   capped   461/461
(100 %)
0 diff
(100 %id)
BX419575 brain, fetal brain .a 158 to 1070 1 to 911       909/911
(99 %)
15 diff
(98.4 %id)
BG821911 adenocarcinoma cell line, colon .a 158 to 805 35 to 688       654/842
(77 %)
13 diff
(98.5 %id)
BG759913 B-cells, primary B-cells from tonsils (cell line) .a 158 to 946 44 to 839       797/839
(94 %)
43 diff
(94.9 %id)
BG761841 melanotic melanoma, high MDR (cell line), skin .a 163 to 833 1 to 671       671/671
(100 %)
1 diff
(99.9 %id)
BG769494 melanotic melanoma, high MDR (cell line), skin .a 163 to 992 1 to 829       829/829
(100 %)
7 diff
(99.2 %id)
AI906047 breast .a 173 to 560 1 to 388       388/389
(99 %)
2 diff
(99.5 %id)
BQ371671 prostate_normal .a 176 to 568 79 to 473       395/473
(83 %)
9 diff
(98.1 %id)
BP306606   .a 187 to 769 1 to 583       583/583
(100 %)
1 diff
(99.9 %id)
CA397367 eye, RPE/choroid .a 199 to 669 1 to 471       471/471
(100 %)
1 diff
(99.8 %id)
AW374349 colon .a 200 to 580 13 to 392       380/394
(96 %)
8 diff
(98.0 %id)
BG327891 Kidney, renal cell adenocarcinoma .a 213 to 807 1 to 608       608/737
(82 %)
28 diff
(96.3 %id)
AI214140 astrocytoma, brain .a 236 to 770 1 to 529     Submitted on the opposite strand 529/537
(98 %)
13 diff
(97.6 %id)
TI_1948102594   .a 260 to 1070 130 to 943 G233R I241V C251L C253V R254P ... fully sequenced,   814/943
(86 %)
18 diff
(98.1 %id)
TI_1948102753   .a 260 to 1073 122 to 933 V121A I230S I231S L232S G233A ... fully sequenced,   814/935
(87 %)
20 diff
(97.9 %id)
BT019761   .a 263 to 1064 1 to 802       802/804
(99 %)
1 diff
(99.9 %id)
BT019762   .a 263 to 1064 1 to 802       802/804
(99 %)
3 diff
(99.7 %id)
CR407650   .a 263 to 1063 1 to 801       801/801
(100 %)
2 diff
(99.8 %id)
CR542255   .a 263 to 1066 1 to 804 exact     804/804
(100 %)
1 diff
(99.9 %id)
CV026704 mixed .a 263 to 896 1 to 628       628/628
(100 %)
13 diff
(98.0 %id)
BP301410   .a 299 to 883 1 to 583       583/583
(100 %)
3 diff
(99.5 %id)
CB111851 Liver .a 306 to 806 1 to 501       501/501
(100 %)
2 diff
(99.7 %id)
TI_154187837   .a 365 to 1233 122 to 984       863/963
(89 %)
35 diff
(96.4 %id)
TI_154188745   .a 365 to 1213 121 to 957       837/938
(89 %)
21 diff
(97.8 %id)
CB049425 Prostate .a 366 to 945 8 to 587       580/587
(98 %)
9 diff
(98.5 %id)
BI916530 brain .a 377 to 1181 1 to 799       799/803
(99 %)
11 diff
(98.7 %id)
TI_57239991   .a 377 to 1181 35 to 833       799/837
(95 %)
17 diff
(98.0 %id)
DA671871   .a 440 to 1013 2 to 575   capped   574/574
(100 %)
1 diff
(99.9 %id)
BP300459   .a 458 to 1038 1 to 581       581/581
(100 %)
4 diff
(99.4 %id)
BP293428 lung .a 459 to 1040 1 to 582       582/582
(100 %)
3 diff
(99.5 %id)
BF348157 anaplastic oligodendroglioma with 1p/19qloss, brain .a 484 to 1237 1 to 743       743/833
(89 %)
19 diff
(97.8 %id)
C18570 placenta .a 505 to 921 1 to 415       415/415
(100 %)
6 diff
(98.6 %id)
BG419570 Kidney, renal cell adenocarcinoma .a 523 to 1275 10 to 750       739/834
(88 %)
38 diff
(95.5 %id)
AA312503   .a 541 to 821 1 to 281       281/281
(100 %)
1 diff
(99.7 %id)
CN265480 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 541 to 1036 1 to 496       496/496
(100 %)
1 diff
(99.8 %id)
BG387020 adenocarcinoma cell line, colon .a 543 to 1362 1 to 809       809/933
(86 %)
29 diff
(96.9 %id)
BF853745 lung_normal .a 547 to 1118 1 to 572       572/572
(100 %)
5 diff
(99.2 %id)
BX348437 Placenta Cot 25-normalized .a 549 to 1402 1 to 850       850/895
(94 %)
15 diff
(98.4 %id)
TI_1948102595   .a 568 to 1065 623 to 126   fully sequenced,   498/623
(79 %)
1 diff
(99.9 %id)
AL576861 placenta, Placenta Cot 25-normalized .a 874 to 1661 797 to 13   fully sequenced,   785/797
(98 %)
0 diff
(100 %id)
TI_1948102754   .a 874 to 1065 314 to 123   fully sequenced,   192/219
(87 %)
1 diff
(99.6 %id)
AL569802 placenta, Placenta Cot 25-normalized .a 894 to 1670 780 to 1   fully sequenced,   780/780
(100 %)
18 diff
(97.7 %id)
AL571890 placenta, Placenta Cot 25-normalized .a 894 to 1670 782 to 1   fully sequenced,   782/782
(100 %)
15 diff
(98.1 %id)
BE293404 adenocarcinoma cell line, colon .a 904 to 1653 763 to 2       759/901
(84 %)
6 diff
(99.4 %id)
BM999853 Fibrosarcoma .a 911 to 1721 811 to 1       811/811
(100 %)
4 diff
(99.6 %id)
BX405861 fetal liver, Liver .a 931 to 1645 714 to 1   fully sequenced,   714/714
(100 %)
3 diff
(99.6 %id)
BE304890 adenocarcinoma cell line, colon .a 937 to 1656 724 to 2       723/725
(99 %)
4 diff
(99.5 %id)
BE293845 adenocarcinoma cell line, colon .a 940 to 1634 723 to 26       698/732
(95 %)
10 diff
(98.7 %id)
AA148488 colon, tumor .a 977 to 1356 1 to 384   fully sequenced,   384/384
(100 %)
9 diff
(97.7 %id)
BM999843 Fibrosarcoma .a 979 to 1721 744 to 1       744/744
(100 %)
6 diff
(99.2 %id)
BQ362692 stomach .a 987 to 1430 20 to 464       445/464
(95 %)
6 diff
(98.8 %id)
AA641265 invasive tumor (cell line), Prostate .a 987 to 1569 577 to 1       577/598
(96 %)
16 diff
(97.4 %id)
BE293802 adenocarcinoma cell line, colon .a 989 to 1634 668 to 16       653/694
(94 %)
0 diff
(100 %id)
BU603386 mixed (pool of 40 RNAs) .a 1027 to 1539 1 to 514       514/905
(56 %)
4 diff
(99.6 %id)
AA640702   .a 1031 to 1453 1 to 419       419/462
(90 %)
18 diff
(96.2 %id)
BG754249 B-cells, primary B-cells from tonsils (cell line) .a 1035 to 1720 1 to 687       687/882
(77 %)
9 diff
(99.0 %id)
CD366157 Alveolar Macrophage, lung .a 1044 to 1721 679 to 1       679/679
(100 %)
2 diff
(99.8 %id)
DB347807 trachea .a 1049 to 1546 509 to 1       509/509
(100 %)
14 diff
(97.3 %id)
BQ641494 eye, normal pigmented retinal epithelium .a 1053 to 1703 1 to 651   AAA Possibly primed on the genome, locally A rich (26/26 A in genome downstream of last aligned base) 651/651
(100 %)
1 diff
(99.9 %id)
BE909262 epithelioid carcinoma, Pancreas .a 1056 to 1700 1 to 649       649/660
(98 %)
13 diff
(98.1 %id)
CD370854 Alveolar Macrophage, lung .a 1060 to 1721 663 to 1       663/663
(100 %)
3 diff
(99.6 %id)
AA401022 ovarian tumor, ovary .a 1080 to 1709 627 to 1       627/627
(100 %)
47 diff
(92.6 %id)
BE676932 follicular carcinoma, thyroid .a 1086 to 1538 476 to 24   AAA Possibly primed on the genome, locally A rich (14/16 A in genome downstream of last aligned base) 453/453
(100 %)
3 diff
(99.4 %id)
AI635272 adenocarcinoma, Pancreas .a 1094 to 1705 613 to 1       613/618
(99 %)
5 diff
(99.2 %id)
BQ348254 head_neck .a 1096 to 1388 15 to 302       288/302
(95 %)
15 diff
(95.1 %id)
AI815000 adenocarcinoma, Pancreas .a 1098 to 1719 621 to 1       621/621
(100 %)
45 diff
(92.8 %id)
BG056190 brain, glioblastoma with probably TP53 mutation andwithout EGFR amplification .a 1103 to 1539 437 to 1       437/437
(100 %)
1 diff
(99.8 %id)
BF907728 uterus_tumor .a 1148 to 1518 1 to 372       372/372
(100 %)
9 diff
(97.6 %id)
AU146189 whole embryo, mainly head .a 1151 to 1703 558 to 1       558/561
(99 %)
20 diff
(96.5 %id)
CD368487 Alveolar Macrophage, lung .a 1157 to 1721 565 to 1       565/565
(100 %)
2 diff
(99.7 %id)
AW339687 myeloid cells, 18 pooled CML cases, BCR/ABLrearrangement positive, includes both chronic phase andmyeloid blast crisis, whole blood .a 1170 to 1703 532 to 1       532/541
(98 %)
9 diff
(98.4 %id)
AW105538 ovary, tumor, 5 pooled (see description) .a 1196 to 1537 342 to 1       342/346
(98 %)
7 diff
(98.0 %id)
BE349302 malignant melanoma, metastatic to lymphnode, skin .a 1207 to 1715 509 to 1       509/509
(100 %)
0 diff
(100 %id)
AU145473 whole embryo, mainly head .a 1209 to 1703 492 to 1       492/562
(87 %)
3 diff
(99.5 %id)
CA438776 lung, Metastatic Chondrosarcoma .a 1216 to 1721 506 to 1       506/513
(98 %)
3 diff
(99.5 %id)
AW003434 normal epithelium, ovary .a 1220 to 1655 511 to 74   AAA   438/506
(86 %)
0 diff
(100 %id)
AA285230   .a 1221 to 1419 1 to 201       201/201
(100 %)
17 diff
(91.6 %id)
BE205860 muscle, rhabdomyosarcoma .a 1223 to 1714 492 to 1       492/492
(100 %)
0 diff
(100 %id)
BU626801 Alveolar Macrophage, lung .a 1225 to 1721 497 to 1       497/497
(100 %)
1 diff
(99.8 %id)
AI365988 brain, oligodendroglioma .a 1262 to 1715 454 to 1       454/454
(100 %)
2 diff
(99.6 %id)
DB377963 placenta .a 1269 to 1698 432 to 6       427/432
(98 %)
0 diff
(100 %id)
AI358229 poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus .a 1315 to 1722 408 to 1       408/408
(100 %)
4 diff
(99.1 %id)
AA861959 squamous cell carcinoma from base of tongue, tongue .a 1320 to 1708 387 to 1       387/387
(100 %)
6 diff
(98.5 %id)
AA148489 colon, tumor .a 1326 to 1710 389 to 1   fully sequenced,   389/389
(100 %)
11 diff
(97.2 %id)
AV740410 cord Blood .a 1329 to 1724 44 to 437       394/463
(85 %)
3 diff
(99.4 %id)
AW406755 lymph .a 1407 to 1836 1 to 431   tiling clone,   431/431
(100 %)
7 diff
(98.4 %id)
TI_154144393   .a 1412 to 1856 80 to 525       446/767
(58 %)
4 diff
(99.5 %id)
CN485135 eye .a 1450 to 2031 1 to 581       581/581
(100 %)
5 diff
(99.2 %id)
BM353004 Pancreas, Purified pancreatic islet .a 1739 to 2184 1 to 446       446/446
(100 %)
0 diff
(100 %id)
BM352716 Pancreas, Purified pancreatic islet .a 1785 to 2298 515 to 2   tiling clone,   514/515
(99 %)
0 diff
(100 %id)
AA356730   .a 1787 to 2016 1 to 230       230/230
(100 %)
1 diff
(99.6 %id)
CK821957 Pancreas, Purified pancreatic islet .a 1834 to 2297 1 to 464   AAA Submitted on the opposite strand 464/464
(100 %)
0 diff
(100 %id)
AW190019 adenocarcinoma, Pancreas .a 1850 to 2303 455 to 2       454/455
(99 %)
0 diff
(100 %id)
CB049574 Prostate .a 1890 to 2011 9 to 130   fully sequenced, Possibly primed on the genome, locally A rich (26/26 A in genome downstream of last aligned base) 122/130
(93 %)
0 diff
(100 %id)
AI870617 anaplastic oligodendroglioma, brain .a 1899 to 2303 409 to 5   tiling clone,   405/409
(99 %)
0 diff
(100 %id)
BI793137 Islets of Langerhans, Pancreas .a 1908 to 2301 1 to 394   fully sequenced,   394/394
(100 %)
1 diff
(99.8 %id)
BI793169 Islets of Langerhans, Pancreas .a 1908 to 2301 1 to 396   fully sequenced,   396/396
(100 %)
7 diff
(98.3 %id)
AI632707 Kidney .a 1923 to 2301 384 to 6       379/384
(98 %)
0 diff
(100 %id)
AI354379 esophagus, squamous cell carcinoma .a 1930 to 2297 368 to 1       368/368
(100 %)
0 diff
(100 %id)
AI524345 Prostate .a 1950 to 2298 349 to 1       349/349
(100 %)
1 diff
(99.8 %id)
AI289057 serous papillary carcinoma, high grade, 2pooled tumors, uterus .a 1960 to 2297 383 to 46   AAA Possibly primed on the genome, locally A rich (26/26 A in genome downstream of last aligned base) 338/338
(100 %)
1 diff
(99.8 %id)
AW168332 bowel (skin primary), metastatic melanoma to bowel .a 1972 to 2302 331 to 1       331/331
(100 %)
0 diff
(100 %id)
AI910641 ovary, tumor, 5 pooled (see description) .a 1978 to 2297 328 to 1       328/328
(100 %)
8 diff
(97.6 %id)
CB049573 Prostate .a 1981 to 2297 349 to 33   fully sequenced, AAA Possibly primed on the genome, locally A rich (26/26 A in genome downstream of last aligned base) 317/317
(100 %)
0 diff
(100 %id)
AJ705151 bone marrow .a 1990 to 2243 1 to 261       261/261
(100 %)
16 diff
(93.9 %id)
C01593   .a 2012 to 2121 1 to 110       110/110
(100 %)
4 diff
(96.4 %id)
BI792900 Islets of Langerhans, Pancreas .a 2051 to 2302 252 to 1   fully sequenced,   252/252
(100 %)
1 diff
(99.7 %id)
BG272383 head/neck, nasopharyngeal carcinoma .a 2055 to 2301 252 to 6       247/275
(89 %)
0 diff
(100 %id)
GD145313   .a 2060 to 2298 1 to 239       239/245
(97 %)
2 diff
(99.2 %id)
CN289422 embryonic stem cells, DMSO-treated H9 cellline .a 2098 to 2302 1 to 205   AAA Possibly primed on the genome, locally A rich (26/26 A in genome downstream of last aligned base) 205/205
(100 %)
0 diff
(100 %id)
BI792870 Islets of Langerhans, Pancreas .a 2104 to 2302 199 to 1   fully sequenced,   199/199
(100 %)
1 diff
(99.5 %id)
BX504868   .a 2116 to 2298 1 to 185       185/224
(82 %)
3 diff
(98.7 %id)
AJ705782 bone marrow .a 2170 to 2297 1 to 129       129/129
(100 %)
5 diff
(96.2 %id)
NM_001024844.1   .b 1 to 1614 1 to 1614 exact RefSeq, AAA Possibly primed on the genome, locally A rich (26/26 A in genome downstream of last aligned base) 1614/1614
(100 %)
0 diff
(100 %id)
BM759265 Ascites, stomach .b 10 to 580 1 to 571   tiling clone,   571/571
(100 %)
2 diff
(99.7 %id)
BI114209 muscle, rhabdomyosarcoma .b 38 to 358 1 to 337       327/947
(34 %)
10 diff
(99.0 %id)
BG569716 lung .b 47 to 492 1 to 446       446/446
(100 %)
1 diff
(99.8 %id)
DB243288 stomach, tumor tissue .b 49 to 353 2 to 306   capped   305/305
(100 %)
0 diff
(100 %id)
AA296179 umbilical vein .b 57 to 242 1 to 185       185/185
(100 %)
1 diff
(99.5 %id)
CD614355   .b 67 to 412 359 to 14       346/359
(96 %)
0 diff
(100 %id)
CD614356   .b 67 to 412 1 to 346       346/360
(96 %)
1 diff
(99.8 %id)
BX474519   .b 72 to 482 1 to 411       411/411
(100 %)
3 diff
(99.3 %id)
AU077255   .b 73 to 298 1 to 226       226/226
(100 %)
0 diff
(100 %id)
DA844648 placenta .b 76 to 428 2 to 355   capped   354/354
(100 %)
1 diff
(99.8 %id)
CD614354   .b 82 to 412 1 to 331       331/345
(95 %)
2 diff
(99.5 %id)
CD614359   .b 82 to 353 1 to 272       272/272
(100 %)
3 diff
(98.9 %id)
CD614353   .b 83 to 412 343 to 14       330/344
(95 %)
0 diff
(100 %id)
CD614360   .b 83 to 416 338 to 7       332/339
(97 %)
1 diff
(99.8 %id)
BE293894 muscle, rhabdomyosarcoma .b 84 to 454 1 to 384       382/384
(99 %)
23 diff
(94.1 %id)
BF850100 lung_normal .b 94 to 472 388 to 12     Submitted on the opposite strand 377/404
(93 %)
0 diff
(100 %id)
CD614358   .b 117 to 412 308 to 13       296/308
(96 %)
0 diff
(100 %id)
CD614357   .b 125 to 388 7 to 268       262/269
(97 %)
23 diff
(91.5 %id)
BF310101 muscle, rhabdomyosarcoma .b 144 to 374 31 to 261       231/268
(86 %)
15 diff
(94.5 %id)
AA933619 adenocarcinoma, colon .b 145 to 422 279 to 1       279/328
(85 %)
12 diff
(96.4 %id)
TI_1948102255   .b 246 to 414 123 to 291       169/193
(87 %)
6 diff
(96.9 %id)
TI_1948102422   .b 246 to 509 121 to 384       264/289
(91 %)
6 diff
(98.0 %id)
AY303776   .b 249 to 977 1 to 729 L99P I216V tiling clone,   729/729
(100 %)
2 diff
(99.8 %id)
BF908644 uterus_tumor .b 508 to 878 25 to 394       370/394
(93 %)
9 diff
(97.8 %id)
BG340987 B-cells, primary B-cells from tonsils (cell line) .b 509 to 1045 1 to 538       538/592
(90 %)
20 diff
(96.7 %id)
AW606519 head_neck .b 510 to 1068 564 to 3       562/571
(98 %)
4 diff
(99.3 %id)
BX334704 Placenta Cot 25-normalized .b 515 to 950 1 to 433       433/433
(100 %)
24 diff
(94.5 %id)
BF038716 adenocarcinoma, ovary .b 525 to 1180 1 to 654       654/654
(100 %)
14 diff
(97.9 %id)
BQ059654 lymph, lymphoma, cell line .b 533 to 1294 1 to 771       771/998
(77 %)
25 diff
(97.5 %id)
BQ898796 lymph, lymphoma, cell line .b 533 to 1387 1 to 869       869/934
(93 %)
31 diff
(96.7 %id)
BE871446 adenocarcinoma, colon .b 541 to 1227 1 to 681   tiling clone,   681/688
(98 %)
8 diff
(98.9 %id)
BF853591 lung_normal .b 542 to 1103 39 to 599       561/599
(93 %)
12 diff
(98.0 %id)
BF663066 B-cells, primary B-cells from tonsils (cell line) .b 556 to 1299 1 to 748       748/904
(82 %)
25 diff
(97.3 %id)
BG761080 melanotic melanoma, high MDR (cell line), skin .b 559 to 1315 1 to 757       757/759
(99 %)
9 diff
(98.9 %id)
BF913243 uterus_tumor .b 578 to 784 1 to 207       207/209
(99 %)
4 diff
(98.1 %id)
BF853613 lung_normal .b 589 to 1201 612 to 1     Submitted on the opposite strand 612/612
(100 %)
7 diff
(98.9 %id)
BE872045 adenocarcinoma, colon .b 631 to 1362 1 to 711       684/936
(73 %)
20 diff
(97.9 %id)
BQ329530 lung_normal .b 644 to 1201 558 to 2       557/558
(99 %)
2 diff
(99.7 %id)
BM762992 myeloma .b 661 to 902 1 to 242       242/244
(99 %)
4 diff
(98.4 %id)
BM763237 myeloma .b 661 to 1338 1 to 678       678/678
(100 %)
3 diff
(99.6 %id)
BM844484 myeloma .b 661 to 1166 1 to 505       505/505
(100 %)
5 diff
(99.1 %id)
BM845237 myeloma .b 661 to 932 1 to 271       271/271
(100 %)
2 diff
(99.3 %id)
AW753756 colon .b 664 to 1092 431 to 3   tiling clone,   429/436
(98 %)
7 diff
(98.4 %id)
BG328568 adenocarcinoma cell line, colon .b 664 to 1414 1 to 744       744/833
(89 %)
25 diff
(97.0 %id)
BG758321 B-cells, primary B-cells from tonsils (cell line) .b 667 to 1470 1 to 801   tiling clone,   801/801
(100 %)
12 diff
(98.6 %id)
AA047157 uterus .b 670 to 904 1 to 236       236/249
(94 %)
5 diff
(98.0 %id)
BE019840 adenocarcinoma cell line, ovary .b 697 to 1338 1 to 648       648/648
(100 %)
10 diff
(98.5 %id)
BE019883 adenocarcinoma cell line, ovary .b 699 to 1242 1 to 547       547/554
(98 %)
14 diff
(97.5 %id)
TI_1948102423   .b 717 to 976 383 to 124       260/287
(90 %)
1 diff
(99.7 %id)
N23960 melanocyte .b 719 to 892 174 to 1       174/174
(100 %)
3 diff
(98.3 %id)
TI_1948102256   .b 727 to 976 375 to 126       250/277
(90 %)
1 diff
(99.7 %id)
BU145222 ductal carcinoma, cell line, Pancreas .b 763 to 1326 1 to 564       564/960
(58 %)
13 diff
(98.7 %id)
BF339977 brain, glioblastoma with EGFR amplification .b 796 to 1558 1 to 758   tiling clone,   758/873
(86 %)
11 diff
(98.8 %id)
BM844088 myeloma .b 833 to 1122 1 to 290       290/290
(100 %)
6 diff
(98.0 %id)
BE158232 head_neck .b 898 to 1070 12 to 183       172/187
(91 %)
3 diff
(98.4 %id)
BI004059 head_normal .b 898 to 1058 39 to 198       160/198
(80 %)
6 diff
(97.0 %id)
BM846993 myeloma .b 898 to 1130 13 to 245       233/245
(95 %)
6 diff
(97.6 %id)
AI432261 adenocarcinoma, breast .b 948 to 1107 4 to 163     Submitted on the opposite strand 160/198
(80 %)
6 diff
(97.0 %id)
BQ347924 head_neck .b 985 to 1221 1 to 239       239/252
(94 %)
12 diff
(95.3 %id)
AA047296 uterus .b 1039 to 1452 414 to 1       414/414
(100 %)
5 diff
(98.8 %id)
F19258 pectoral muscle (after mastectomy) .b 1272 to 1458 1 to 187   tiling clone,   187/187
(100 %)
1 diff
(99.5 %id)
CB127804 cervix, Uterine .c 1 to 475 1 to 475   tiling clone,   475/475
(100 %)
2 diff
(99.6 %id)
AV737307 cord Blood .c 55 to 400 44 to 378       335/413
(81 %)
13 diff
(96.9 %id)
CB996890 placenta, pre-eclamptic placenta .c 60 to 706 28 to 675       648/821
(78 %)
19 diff
(97.7 %id)
CB992570 placenta, pre-eclamptic placenta .c 60 to 761 28 to 728       701/832
(84 %)
11 diff
(98.7 %id)
CB961398 placenta, pre-eclamptic placenta .c 60 to 736 28 to 705       678/792
(85 %)
14 diff
(98.3 %id)
BG545505 lung .c 61 to 602 1 to 562       529/795
(66 %)
27 diff
(96.7 %id)
BP302541   .c 62 to 611 1 to 550       550/550
(100 %)
2 diff
(99.7 %id)
BP192910 brain .c 63 to 644 1 to 582   tiling clone,   582/582
(100 %)
0 diff
(100 %id)
BI544978 brain, hippocampus .c 86 to 679 1 to 594       594/594
(100 %)
4 diff
(99.4 %id)
BP295502   .c 87 to 670 1 to 583       583/583
(100 %)
2 diff
(99.7 %id)
BP366714 thymus .c 87 to 663 1 to 578       578/578
(100 %)
20 diff
(96.6 %id)
BU594303 mixed (pool of 40 RNAs) .c 88 to 911 1 to 830   tiling clone,   830/831
(99 %)
21 diff
(97.5 %id)
AA985344 schizophrenic brain S-11 frontal lobe .c 93 to 451 1 to 359     Submitted on the opposite strand 359/359
(100 %)
2 diff
(99.5 %id)
R48076 breast .c 808 to 1252 1 to 450       450/450
(100 %)
20 diff
(95.6 %id)
BX110806 breast .c 811 to 1567 1 to 757   tiling clone,   757/757
(100 %)
1 diff
(99.9 %id)
R47965 breast .c 1282 to 1621 344 to 1   tiling clone,   344/344
(100 %)
12 diff
(96.6 %id)
BG340815 B-cells, primary B-cells from tonsils (cell line) .d 1 to 666 1 to 668   tiling clone,   668/923
(72 %)
11 diff
(98.9 %id)
BG759484 B-cells, primary B-cells from tonsils (cell line) .d 1 to 731 1 to 730 V205L I210V K232R V233S tiling clone,   730/732
(99 %)
6 diff
(99.2 %id)
CR735172 ovary, teratocarcinoma, cell line .d 2 to 500 38 to 536   tiling clone,   499/536
(93 %)
7 diff
(98.7 %id)
BF238081 B-cells, primary B-cells from tonsils (cell line) .e 1 to 707 1 to 706       703/980
(71 %)
29 diff
(97.1 %id)
BG755086 B-cells, primary B-cells from tonsils (cell line) .e 1 to 892 1 to 875 H202P V203S H204I S205P E206K ...     875/996
(87 %)
41 diff
(95.9 %id)
BG759830 B-cells, primary B-cells from tonsils (cell line) .e 1 to 725 1 to 724   tiling clone,   724/724
(100 %)
3 diff
(99.6 %id)
BG122103 adenocarcinoma, cell line, Liver .e 70 to 756 1 to 684 I44M A45P Q46R V47*     684/726
(94 %)
5 diff
(99.4 %id)
BU185132 adenocarcinoma, Pancreas .e 96 to 942 1 to 849   tiling clone,   849/918
(92 %)
8 diff
(99.2 %id)
BU196310 adenocarcinoma, Pancreas .e 96 to 1007 1 to 919   tiling clone,   919/919
(100 %)
27 diff
(97.1 %id)
BG682281 skin, squamous cell carcinoma .e 857 to 1266 1 to 410   tiling clone, AAA Possibly primed on the genome, locally A rich (26/26 A in genome downstream of last aligned base) 410/414
(99 %)
1 diff
(99.8 %id)
BG323223 Kidney, renal cell adenocarcinoma .f 1 to 827 1 to 668   tiling clone,   646/1221
(52 %)
21 diff
(98.3 %id)
BQ056741 lymph, lymphoma, cell line .f 558 to 1404 1 to 857   tiling clone,   857/1034
(82 %)
21 diff
(98.0 %id)
BQ060101 lymph, lymphoma, cell line .f 558 to 1211 1 to 654   tiling clone,   654/996
(65 %)
10 diff
(99.0 %id)
BG684390 B-cells, primary B-cells from tonsils (cell line) .f 616 to 1221 1 to 606       606/606
(100 %)
4 diff
(99.4 %id)
BP297374   .g 1 to 580 1 to 581   tiling clone,   581/581
(100 %)
1 diff
(99.9 %id)
BF838396 head_neck .g 104 to 633 557 to 29   tiling clone, Submitted on the opposite strand 529/557
(94 %)
1 diff
(99.9 %id)
DB106242 thymus .h 1 to 544 2 to 545 V122A tiling clone, capped   544/544
(100 %)
2 diff
(99.7 %id)
BP213479 cerebrum .i 1 to 563 6 to 568 exact tiling clone,   568/577
(98 %)
1 diff
(99.9 %id)
BU785750 Pancreas, Purified pancreatic islet .i 22 to 562 1 to 541       541/541
(100 %)
0 diff
(100 %id)
BP264285 small intestine .j 1 to 582 1 to 582 exact tiling clone,   582/582
(100 %)
3 diff
(99.5 %id)
AA362234   .k-u 1 to 295 1 to 296   tiling clone,   296/296
(100 %)
1 diff
(99.7 %id)
AV736612 cord Blood .l 1 to 440 47 to 471 A34G Q35T A36G E37R V38S ... tiling clone,   430/486
(88 %)
24 diff
(95.1 %id)
BP297276   .m 1 to 581 1 to 581 exact tiling clone,   581/581
(100 %)
0 diff
(100 %id)
DB053142 testis .n 1 to 572 2 to 574 C22V D23T Q24S L25C H26T ... tiling clone, capped   573/573
(100 %)
4 diff
(99.4 %id)
BP297544   .o 1 to 581 1 to 581 exact tiling clone,   581/581
(100 %)
0 diff
(100 %id)
BP297577   .o 1 to 580 1 to 580       580/580
(100 %)
0 diff
(100 %id)
DA703865   .p 1 to 480 2 to 482 G31R V32G W33V I34D L35P ... tiling clone, capped   481/481
(100 %)
1 diff
(99.8 %id)
DA705166   .p 2 to 468 2 to 468   tiling clone, capped   467/467
(100 %)
0 diff
(100 %id)
BG654995 Pancreas, Purified pancreatic islet .q-u 1 to 457 10 to 466 exact tiling clone,   457/466
(98 %)
6 diff
(98.8 %id)
BE832503 marrow .q-u 17 to 319 2 to 313       312/313
(99 %)
6 diff
(98.1 %id)
AW951166   Gene CD82, variant not shown              
DA763265 tongue Gene CD82, variant not shown       capped This clone was ignored    
BP324348 Pancreas Gene CD82, variant not shown         Suspected internal deletion, this clone was ignored    
CF887477 lung, Primary Lung Cystic Fibrosis EpithelialCells Gene CD82, variant not shown         This clone was ignored    
CF890874 lung, Primary Lung Cystic Fibrosis EpithelialCells Gene CD82, variant not shown         This clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i, .j, .k-u, .l, .m, .n, .o, .p, .q-u Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes DCI